We observed an unexpected trend towards improved TTP in patients with tumours with strong Akt2 expression (13.1 vs. 7.2 months) but the difference was not statistically significant (P=0.133; HR 0.682; 95% CI 0.42–1.12). Here, AKT2 is linked to neoplasm.